Neuroinflammation and Biomarker Discovery
From Mechanisms to Clinical Application
- 1st Edition - March 1, 2027
- Latest edition
- Editors: Arun Kumar Singh, Meenakshi Dhanawat
- Language: English
Neuroinflammation and Biomarker Discovery: From Mechanisms to Clinical Application offers a detailed exploration of the molecular and cellular processes underlying neuroi… Read more
Description
Description
Neuroinflammation and Biomarker Discovery: From Mechanisms to Clinical Application offers a detailed exploration of the molecular and cellular processes underlying neuroinflammatory conditions. This essential reference addresses the urgent need for advanced biomarkers that can facilitate early diagnosis, monitor disease progression, and guide personalized treatments in neurodegenerative and autoimmune disorders such as Alzheimer’s disease, Parkinson’s disease, and multiple sclerosis. The book synthesizes current knowledge on neuroimmune interactions, glial cell activation, blood-brain barrier integrity, and innate immune signaling pathways, providing a comprehensive framework for understanding neuroinflammatory mechanisms. It also covers state-of-the-art platforms for biomarker discovery, including transcriptomics, proteomics, lipidomics, epigenomics, extracellular vesicles, and neuroimaging techniques, emphasizing their translational potential. The inclusion of disease-specific biomarker landscapes enhances its relevance for clinicians and researchers working in diagnostics and drug development. The final sections focus on translational applications, such as clinical trial design, biomarker validation, and the integration of AI-driven multi-omics data for personalized neuroimmunology. This volume is an indispensable resource for neuroscientists, clinicians, graduate students, biotech professionals, and data scientists seeking to advance understanding and innovation in neuroinflammatory research and clinical practice. By bridging basic science and clinical application, it aims to accelerate the development of targeted therapies and diagnostic tools, ultimately improving patient outcomes in neuroinflammatory diseases
Key features
Key features
- Explains neuroinflammatory mechanisms at molecular and cellular levels
- Connects research findings to clinical diagnostics and therapeutic strategies
- Provides disease-specific biomarker profiles for neurodegenerative and autoimmune disorders
- Highlights cutting-edge imaging platforms for biomarker discovery
Readership
Readership
Neuroscientists and clinicians specializing in neurodegenerative diseases
Table of contents
Table of contents
SECTION I: MOLECULAR AND CELLULAR FRAMEWORK OF NEUROINFLAMMATION
1. The Neuroimmune Axis: Cellular Interfaces and Bidirectional Signaling
2. Microglial Activation States: From Homeostasis to Neurotoxicity
3. Astrocyte and Oligodendrocyte Contribution to Neuroinflammation
4. Pattern Recognition Receptors and CNS Innate Immunity
5. Molecular Triggers: DAMPs, PAMPs, and the Inflammasome Complex
6. Blood-Brain Barrier Breakdown and Immune Cell Trafficking
SECTION II: SIGNALING NETWORKS IN NEUROINFLAMMATORY PATHWAYS
7. NF-κB and MAPK Pathways: Master Regulators of Inflammatory Transcription
8. JAK/STAT Signaling and Interferon Regulatory Networks in the CNS
9. Redox Signaling, ROS Generation, and Mitochondrial Dysfunction
10. Autophagy, Ubiquitin-Proteasome System, and Immune Regulation
SECTION III: ADVANCED PLATFORMS FOR BIOMARKER DISCOVERY
11. Transcriptomic Approaches: Bulk RNA-Seq and Single-Cell Resolution
12. Proteomics and Phosphoproteomics in Neuroinflammation
13. Lipidomics and Metabolomics of Inflammatory Brain States
14. Epigenomic Biomarkers: DNA Methylation, Histone Modifications, and miRNAs
15. Extracellular Vesicles and Exosomal Biomarkers in Neuroinflammatory Diseases
16. Imaging Biomarkers: PET, MRI, and Molecular Neuroimaging
SECTION IV: DISEASE-SPECIFIC BIOMARKER LANDSCAPES
17. Neuroinflammation in Alzheimer's Disease: Aβ, Tau, and Microglial Dysfunction
18. Biomarkers of Neuroinflammation in Parkinson’s Disease and Lewy Body Disorders
19. Multiple Sclerosis and Autoimmune Neuroinflammation
20. Stroke, Traumatic Brain Injury, and Post-Injury Neuroinflammation
21. Vascular Ageing and its Impact on Brain Health
22. Epstein–Barr Virus (EBV) and Multiple Sclerosis
23. Herpes Simplex Virus (HSV) and Alzheimer's Disease
SECTION V: TRANSLATIONAL APPLICATIONS AND FUTURE DIRECTIONS
24. Biomarkers in Clinical Trials: Stratification, Monitoring, and Endpoints
25. Toward Personalized Neuroimmunology: AI-Driven Integration of Multi-Omics Data
1. The Neuroimmune Axis: Cellular Interfaces and Bidirectional Signaling
2. Microglial Activation States: From Homeostasis to Neurotoxicity
3. Astrocyte and Oligodendrocyte Contribution to Neuroinflammation
4. Pattern Recognition Receptors and CNS Innate Immunity
5. Molecular Triggers: DAMPs, PAMPs, and the Inflammasome Complex
6. Blood-Brain Barrier Breakdown and Immune Cell Trafficking
SECTION II: SIGNALING NETWORKS IN NEUROINFLAMMATORY PATHWAYS
7. NF-κB and MAPK Pathways: Master Regulators of Inflammatory Transcription
8. JAK/STAT Signaling and Interferon Regulatory Networks in the CNS
9. Redox Signaling, ROS Generation, and Mitochondrial Dysfunction
10. Autophagy, Ubiquitin-Proteasome System, and Immune Regulation
SECTION III: ADVANCED PLATFORMS FOR BIOMARKER DISCOVERY
11. Transcriptomic Approaches: Bulk RNA-Seq and Single-Cell Resolution
12. Proteomics and Phosphoproteomics in Neuroinflammation
13. Lipidomics and Metabolomics of Inflammatory Brain States
14. Epigenomic Biomarkers: DNA Methylation, Histone Modifications, and miRNAs
15. Extracellular Vesicles and Exosomal Biomarkers in Neuroinflammatory Diseases
16. Imaging Biomarkers: PET, MRI, and Molecular Neuroimaging
SECTION IV: DISEASE-SPECIFIC BIOMARKER LANDSCAPES
17. Neuroinflammation in Alzheimer's Disease: Aβ, Tau, and Microglial Dysfunction
18. Biomarkers of Neuroinflammation in Parkinson’s Disease and Lewy Body Disorders
19. Multiple Sclerosis and Autoimmune Neuroinflammation
20. Stroke, Traumatic Brain Injury, and Post-Injury Neuroinflammation
21. Vascular Ageing and its Impact on Brain Health
22. Epstein–Barr Virus (EBV) and Multiple Sclerosis
23. Herpes Simplex Virus (HSV) and Alzheimer's Disease
SECTION V: TRANSLATIONAL APPLICATIONS AND FUTURE DIRECTIONS
24. Biomarkers in Clinical Trials: Stratification, Monitoring, and Endpoints
25. Toward Personalized Neuroimmunology: AI-Driven Integration of Multi-Omics Data
Product details
Product details
- Edition: 1
- Latest edition
- Published: March 1, 2027
- Language: English
About the editors
About the editors
AS
Arun Kumar Singh
Arun Kumar Singh is an Assistant Professor in the Department of Pharmacy at University School of Pharmaceutical Sciences, Rayat Bahra University V.P.O. Sahauran, India. He completed his M.Pharm in Pharmaceutics from Galgotias University, Greater Noida. His research interests include nano-formulation, blockchain, IoT, machine learning, artificial intelligence, big data analytics, cancer biology, and neuroscience. He has contributed to academic books and book chapters and has published review articles in the areas of pharmaceutical sciences and healthcare technology. His work focuses on interdisciplinary approaches integrating pharmaceutical research with emerging digital and computational technologies.
Affiliations and expertise
Assistant Professor, University School of Pharmaceutical Sciences, Rayat Bahra University V.P.O. Sahauran, Tehsil Kharar, Distt. Mohali, Punjab, IndiaMD
Meenakshi Dhanawat
Dr. Meenakshi Dhanawat is an Associate Professor at the Amity Institute of Pharmacy, Amity University Haryana, with many years of experience in Pharmaceutical Sciences and Medicinal Chemistry. She completed her Master's degree at NIPER, Mohali, focusing on glycosylamino acids, and earned her Ph.D. from IIT-BHU, Varanasi, investigating CNS drug delivery targeting 5HT1A/2A receptors. Her research encompasses synthetic and heterocyclic chemistry, nanotechnology, drug delivery systems, prodrug design, complexation, polymer chemistry, and herbal drug extraction. Dr. Dhanawat has received notable international recognition, including a travel grant from the AAPS Drug Delivery and Development section for the 2010 National Biotechnology Conference in California, and international travel grants from DBT and DST, Government of India, for conferences in California and Munich. Her distinguished honors include the Rajiv Gandhi National Fellowship, affirming her sustained contributions to pharmaceutical research and academic excellence.
Affiliations and expertise
Associate Professor, Amity Institute of Pharmacy, Amity University, Haryana, India